S
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need to be treated to elicit a significant difference in mortality. Moreover, follow-up periods in all but 1 trial (6) and in most studies, including the current study (12) , were too short to reveal a survival advantage favoring surgery.
There was a similar trend for the composite endpoint of mortality, MI, and/or stroke, despite the performance of almost one-half of the CABG procedures using a cardiopulmonary bypass (CPB) machine, which accounts for the majority of The current series confirms repeat TVR as the Achilles heel of PCI, even in the era of DES. Although most repeat TVRs occur within the first post-PCI year (6, 15) , the repeat revascularization rate remains significantly higher than for surgery, even at 10 years (6, 14) . The reasons for this may be multifactorial.
First, most CABG patients receive a LIMA to LAD graft, which has a patency rate as high as 95% to 98%
at 10-to 20-year follow-up (17) . Secondly, bypass grafts provide an alternative source of inflow and an outflow point that is commonly located substantially distal to the diseased LAD segment, which protects against future disease development and progression.
In contrast, PCI is performed within the diseased segment of the LAD, subjecting the distal vessel to In summary, although the current study (12) reported no differences in mortality or in the composite endpoint of mortality, MI, and/or stroke between CABG and DES, it did provide further evidence that repeat TVR occurs significantly more frequently after PCI of the proximal LAD than after CABG, even in real-world practice. 
